Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-09

Clinical Trial Update: Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how weight and obesity influence anidulafungin drug concentrations; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anidulafungin (anidulafungin)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Obesity, Mycoses | Phase 4 | Status: COMPLETED | Results posted: 2019-01-09